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Descrevemos neste trabalho nossa rota sintética para obtenção do policetídeo antifúngico 
(-)-basiliskamida A, assim como estudos de RMN de 1H relacionados a migração da cadeia lateral 
cinamoíla da basiliskamida A para formar a basiliskamida B em CDCl
3
.
We describe herein our approach to the total synthesis of the antifungal polyketide 
(-)-basiliskamide A, as well as 1H NMR studies on the migration of the cinnamoyl side chain of 
basiliskamide A to form basiliskamide B in CDCl
3
 solution.
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Introduction
The polyketides basiliskamides A (1) and B (2) were 
isolated from the marine bacterium PNG-276 from the 
coast of Papua New Guinea (Figure 1).1,2 These antifungal 
polyketides show potent in vitro activity against Candida 
albicans and Aspergillus fumigatus,1 as well as at least 
4-fold less cytotoxicity for normal human fibroblast 
cells when compared to amphotericin B.1,3 The relative 
configurations of basiliskamides A (1) and B (2) were 
proposed by Andersen and co-workers1 and the absolute 
configurations have been confirmed by total synthesis.4
We have recently concluded the total synthesis of 
basiliskamide B.5 As the natural supply of basiliskamide 
A is restricted, and attracted by its potent cytotoxicity, we 
initiated a project directed towards an efficient and flexible 
total synthesis, in order to provide further material for 
more extensive biological studies, along with access to 
novel analogs.6 
Results and Discussion
Our approach for the preparation of (-)-basiliskamide 
A (1) began with the synthesis of vinyl iodide 4, prepared 
in 7 steps and 19.1% overall yield from ethylketone 3 
(Scheme 1).5,7 
The next step involved a Stille cross-coupling 
reaction between Z-vinylstannane 58 and E-vinyl iodide 4 
(Scheme 2). This was accomplished by treatment of 4 and 5 




 at 50 oC, 
providing 6 in 60% yield after purification by silica-gel 
column chromatography. At this point only four synthetic 
operations remained to conclude the total synthesis of 
(-)-basiliskamide A. Removal of the isopropylidene acetal 
protecting group in 6 with 80% AcOH provided diol 7. 
Selective protection of the less hindered oxygen with 
TES chloride in the presence of pyridine gave alcohol 


















Figure 1. Basiliskamides A and B.
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8 with E-cinnamoyl chloride in the presence of DMAP 
and Et
3
N gave ester 9, which, after treatment with HF in 
acetonitrile, provided (-)-basiliskamide A in 42% for the 
four-step sequence. 
The spectroscopic and physical data (1H and 13C NMR, 
IR, [a]D, R
f
) for synthetic (-)-basiliskamide A were 
identical in all respects with the published data for the 
natural product.1,4
NMR studies
At this point, we decided to investigate the possibility 
of basiliskamide B being produced by cinnamoyl side 
chain migration from basiliskamide A. To this end, we 
did an NMR study to verify whether the conversion of 
basiliskamide A to basiliskamide B in mild acidic CDCl
3
 
solution was possible or not (Scheme 3). This conversion 
would occur through migration of the cinnamoyl side chain 
from the more hindered oxygen at C9 in basiliskamide A 
to the less hindered oxygen at C7.
In the 1H NMR spectrum of basiliskamide A (1), the 
signal at d 3.63 ppm (dt, J 3.5 and 10.0 Hz) is attributed to 
the hydrogen H7. In the 1H NMR spectrum of basiliskamide 
B the signal at d 3.35 ppm (dd, J 2.5 and 9.5 Hz) refers to 
the hydrogen H9 (Figure 2).
After 24 h, the 1H NMR spectrum of basiliskamide A (1) 
shows a new signal at d 3.35 ppm, which corresponds to the 
hydrogen H9 of basiliskamide B (Figure 3). After 20 days, we 
can observe that the signal at d 3.35 ppm increases leading to 
a 1.00:0.45 ratio of basiliskamide A (1) and basiliskamide B 
(2), respectively. This clearly shows that the migration of the 
cinnamoyl side chain is occurring and that it is possible that 
basiliskamide B is an artifact of basiliskamide A.10
Conclusions
In summary, a highly convergent and efficient total 
synthesis of (-)-basiliskamide A has been accomplished. 
The synthesis required 15 steps from ethylketone 3 and 
produced the desired product in 3.2% overall yield. This 
approach compares very well with the published routes to 
(-)-basiliskamide A4 and the synthetic strategy presented 































































































Scheme 2. Total synthesis of (-)-basiliskamide A.
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Figure 2. Chemical shifts in the 1H NMR spectrum (CDCl
3
, 500 MHz) of H7 in basiliskamide A (1) and H9 in basiliskamide B (2).
Experimental 
(-)-Basiliskamide A (1) 
The diene 6 (68.5 mg, 0.23 mmol) was dissolved in 80% 
acetic acid (5 mL). The reaction was protected from light 
and stirred at 60 oC for 3 h. The reaction was then allowed 
to reach ambient temperature and adjusted to pH 7.0 with 
NH
4
OH. The aqueous phase was extracted with EtOAc 
(2 × 10 mL), the combined organic extracts were dried over 
MgSO
4
, filtered and concentrated under reduced pressure 
to give the corresponding diol 7. R
f
 = 0.15 (hexane:EtOAc, 
50:50). [a]
D
25 = +15 (c = 0.35, CHCl
3
). 1H NMR (DMSO-d
6
, 
250 MHz): d 0.69 (d, 3H, J 7.0 Hz); 0.73 (d, 3H, J 6.3 Hz); 
0.84 (t, 3H, J 7.3 Hz); 1.35 (m, 3H), 1.61 (m, 1H); 2.05 (m, 
1H); 2.28 (m, 1H); 3.24 (m, 1H); 3.81 (m, 1H); 4.49 (d, 1H, 
J 5.3 Hz); 4.7 (d, 1H, J 4.7 Hz); 5.58 (d, 1H, J 5.6 Hz); 6.03 
(dt, 1H, J 6.0 Hz); 6.37 (t, 1H, J 11.5 Hz); 6.86 (brs, 1H); 
7.37 (brs, 1H);7.45 (dd, 1H, J 11.5 e 15.5 Hz). 13C NMR 
(DMSO-d
6
, 62.5 MHz): d 11.3; 12.4; 12.5; 27.22; 35.9; 36.8; 
41.9; 71.9; 74.8; 119.6; 128.5; 141.2; 141.3; 168.1. IR (film) 
n
max







+]: expected: 256.1907; observed: 256.1913. 
A solution of the corresponding crude diol 7 obtained 
before (44.8 mg; 0.18 mmol) in pyridine (3 mL) was treated 
with TESCl (0.033 mL; 0.19 mmol) at 0 oC, and stirred at 





 solution and extracted with EtOAc 
providing alcohol 8. R
f





, 250 MHz): d 0.73 (q, 6H, J 8 Hz); 0.84 
(d, 3H, J 6.8 Hz); 1.01 (m, 6H); 1.12 (t, 9H, J 8 Hz); 1.49 
(m, 3H); 2.02 (m, 1H); 2.43 (t, 2H, J 6.3 Hz); 2.67 (brd, 
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Figure 3. Partial 1H NMR spectrum (CDCl
3
, 500 MHz) showing the migration of the cinnamoyl side chain after 24 h and after 20 days.
1H, J 3.3 Hz); 3.44 (brd, 1H, J 8.5 Hz); 4.23 (q, 1H, J 5.3 
Hz); 4.72 (brs, 1H); 5.19 (d, 1H, J 11.3 Hz); 5.59 (brs, 1H); 
6.25 (dt, 1H, J 7.3 e 15.5 Hz); 6.39 (t, 1H, J 11.3 Hz); 8.17 




, 62.5 MHz): 
d 5.5; 7.2; 11.3; 11.8; 12.4; 27.6; 36.8; 37.2; 42.1; 75.2; 
75.6; 118.2; 129.6; 141.1; 142.6; 168.1.




 (0.7 mL) 
was treated with Et
3
N (0.034 mL; 0.24 mmol) and DMAP 
(1.7 mg, 0.014 mmol) and cooled to 0 oC. The solution was 
treated with (E)-cinnamoyl chloride (0.02 g; 0.12 mmol). 
The reaction was protected from light and stirred at ambient 
temperature for 18 h, and the reaction was then quenched 





and the solvent was removed under reduced pressure 
to provide ester 9. R
f







25 = -77 (c 0.26, MeOH). 1H NMR (CDCl
3
, 500 MHz): 
d 0.83 (d, 3H, J 7.0 Hz); 0.84 (d, 3H, J 7.0 Hz); 0.87 (t, 3H, 
J 7.5 Hz); 0.90 (d, 3H, J 7.0 Hz); 1.11 (m, 1H) 1.25 (m, 
1H); 1.67 (m, 1H); 1.99 (m, 1H); 2.06 (m, 1H); 2.28 (m, 
1H); 3.49 (m, 1H); 4.57 (d, 1H, J 5.0 Hz); 4.92 (dd, 1H; 
J 2.0 e 9.5 Hz); 5.55 (d, 1H, J 11.0 Hz); 5.91 (dt, 1H, J 7.0 e 
15.0 Hz); 6.31 (brt, 1H, J 11.0 Hz); 6.61 (d, 1H, J 16.0 Hz); 
6.83 (s, 1H); 7.31 (s, 1H); 7.40 (dd, 1H, J 11.0 e 15.0 Hz); 
7.41 (m, 2H); 7.65 (d, 1H, J 16.0 Hz); 7.71 (m, 2H). 
13C NMR (CDCl
3
, 100 MHz): d 10.1; 11.6; 12.8; 26.4; 34.7; 
35.5; 40.8; 69.7; 76.3; 118.0; 119.3; 128.2; 128.4; 128.9; 
130.4; 134.0; 140.56; 140.58; 144.6; 166.1; 167.5. IR (film) 
n
max
/cm-1: 3367, 2966, 2936, 1701, 1670, 1588.
The crude compound 9 (0.029 mmol) was treated 
with 0.4 mL of a solution of HF (40% aqueous solution): 
CH
3
CN (1:18). After 10 min at r.t. the reaction was 
quenched with NaHCO
3
 (4 mg) and stirred for 10 min, 





, 4:2) afforded 
(-)-basiliskamide A (1) (4.6 mg, 42% yield, 4 steps). 
R
f




, 40:10). 1H NMR (DMSO-d
6
, 5000 
MHz): d 7.72 (2H, m); 7.66 (1H, d, 16.0 Hz); 7.41 (3H, m); 
7.41 (3H, m); 7.39 (1H, m); 7.33 (1H, brs); 6.84 (1H, brs); 
6.62 (1H, d, 16.0 Hz); 6.31 (1H, apt, 11.5 Hz); 5.91 (1H, dt, 
7.4 and 14.9 Hz); 5.55 (1H, d, 11.5 Hz); 4.92 (1H, dd, 2.6 
and 9.5 Hz); 4.58 (1H, d, 5.4 Hz); 3.48 (1H, m); 2.28 (1H, 
m); 2.02 (1H, m); 2.02 (1H, m), 1.67 (1H, m); 1.25 (1H, 
m); 1.11 (1H, m); 0.89 (3H, d, 6.6 Hz); 0.87 (3H, t, 7.7 Hz); 
0.84 (3H, d, 7.1 Hz) ppm. 13C NMR (DMSO-d
6
, 125 MHz): 
d 167.5; 166.1; 144.6; 140.56; 140.51; 134.0; 130.4; 128.9; 
128.4; 128.3; 119.4; 118.0; 76.3; 69.7; 40.8; 35.5; 34.7; 26.4; 
12.8; 11.7; 10.1 ppm.
Supplementary Information 
Supplementary data are available free of charge at 
http://jbcs.sbq.org.br, as a PDF file.
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Figure S1. 1H NMR of acetonide 6 (DMSO-d
6
, 250 MHz).
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Figure S2. 13C NMR of acetonide 6 (DMSO-d
6
, 62.5 MHz).
Figure S3. IR of acetonide 6.
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Figure S4. 1H NMR of diol 7 (DMSO-d
6
, 250 MHz).
Figure S5. 13C NMR of diol 7 (DMSO-d
6
, 62.5 MHz).
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Figure S6. IR of diol 7. 
Figure S7. HRMS of diol 7.
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Figure S8. 1H NMR of basiliskamide A (1), (DMSO-d
6
, 500 MHz).
Figure S9. 13C NMR of basiliskamide A (1), (DMSO-d
6
, 125 MHz).
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Table 1. Comparison of 1H and 13C NMR data for natural1 and our synthetic basiliskamide A (DMSO-d
6
) 
1H NMR (400 MHz)
 d/ppm (number of hydrogens, 
multiplicity, coupling constant)
Natural
1H NMR (500 MHz)
d/ppm (number of hydrogens, 
multiplicity, coupling constant)
Synthetic
13C NMR (100 MHz)1
d (ppm)
Natural 
13C NMR (125 MHz)1
d (ppm)
Synthetic
0.84 (3H, d, 7.0 Hz) 0.84 (3H, d, 7.1 Hz) 10.1 10.1
0.87 (3H, t, 7.5 Hz) 0.87 (3H, t, 7.7 Hz) 11.6 11.7
0.90 (3H, d, 7.0 Hz) 0.89 (3H, d, 6.6 Hz) 12.8 12.8
1.11 (1H, m) 1.11 (1H, m) 26.4 26.4
1.25 (1H, m) 1.25 (1H, m) 34.7 34.7
1.67 (1H, m) 1.67 (1H, m) 35.5 35.5
1.99 (1H, m) 2.02 (1H, m) 40.7 40.8
2.06 (1H, m) 2.04 (1H, m) 69.6 69.7
2.28 (1H, m) 2.28 (1H, m) 76.3 76.3
3.49 (1H, m) 3.48 (1H, m) 118.0 118.0
4.57 (1H, d, 5.0 Hz) 4.58 (1H, d, 5.4 Hz) 119.3 119.4
4.92 (1H, dd, 2.0 and 9.5 Hz) 4.92 (1H, dd, 2.6 and 9.5 Hz) 128.2 128.3
5.55 (1H, d, 11.0 Hz) 5.55 (1H, d, 11.5 Hz) 128.4 128.4
5.91 (1H, dt, 7.0 and 15.0 Hz) 5.91 (1H, dt, 7.4 and 14.9 Hz) 128.9 128.9
6.31 (1H, dd, 11.0 and 11.0 Hz) 6.31 (1H, apt, 11.3 Hz) 130.4 130.4
6.61 (1H, d, 16.0 Hz) 6.62 (1H, d, 15.9 Hz) 134.0 134.0
6.83 (1H, s) 6.84 (1H, brs) 140.5 140.51
7.31 (1H, s) 7.33 (1H, brs) - 140.56
7.40 (1H, dd, 11.0 and 15.0 Hz) 7.39 (1H, m) 144.6 144.6
7.40 (1H, m) 7.41 (3H, m) 166.0 166.1
7.41 (2H, m) - 167.4 167.5
7.65 (1H, d, 16.0 Hz) 7.66 (1H, d, 16.0 Hz) - -
7.71 (2H, m) 7.72 (2H, m) - -
1. Barsby, T.; Kelly, M. T.; Andersen R. J.; J. Nat. Prod. 2002, 65, 1447; Kelly, M. T.; Anderson, R. J.; Barsby, T.; US Patent 2005/0277779 A1, 2005.
Figure S10. IR of basiliskamide A (1).
